KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Work In Process (2016 - 2025)

Historic Work In Process for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to $25.2 million.

  • Pacific Biosciences Of California's Work In Process rose 3770.5% to $25.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.2 million, marking a year-over-year increase of 3770.5%. This contributed to the annual value of $22.2 million for FY2024, which is 1982.06% down from last year.
  • Pacific Biosciences Of California's Work In Process amounted to $25.2 million in Q3 2025, which was up 3770.5% from $26.9 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Work In Process ranged from a high of $27.9 million in Q3 2023 and a low of $6.9 million during Q1 2021
  • Over the past 5 years, Pacific Biosciences Of California's median Work In Process value was $21.7 million (recorded in 2024), while the average stood at $18.3 million.
  • Per our database at Business Quant, Pacific Biosciences Of California's Work In Process soared by 13587.26% in 2023 and then crashed by 3439.73% in 2024.
  • Pacific Biosciences Of California's Work In Process (Quarter) stood at $8.6 million in 2021, then soared by 63.3% to $14.1 million in 2022, then soared by 96.65% to $27.7 million in 2023, then dropped by 19.82% to $22.2 million in 2024, then grew by 13.61% to $25.2 million in 2025.
  • Its last three reported values are $25.2 million in Q3 2025, $26.9 million for Q2 2025, and $24.9 million during Q1 2025.